These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3749526)

  • 1. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
    Schick RR; Yaksh TL; Go VL
    Regul Pept; 1986 Jul; 14(4):277-91. PubMed ID: 3749526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide.
    Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Södersten P
    J Endocrinol; 1989 Apr; 121(1):59-65. PubMed ID: 2565947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cholecystokinin octapeptide analogues on food intake in the dog.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Oimomi M; Baba S
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R946-51. PubMed ID: 2802006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sites in the brain at which cholecystokinin octapeptide (CCK-8) acts to suppress feeding in rats: a mapping study.
    Schick RR; Harty GJ; Yaksh TL; Go VL
    Neuropharmacology; 1990 Feb; 29(2):109-18. PubMed ID: 2330072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic intraventricular administration of cholecystokinin octapeptide (CCK-8) suppresses feeding in rats.
    Schick RR; Stevens CW; Yaksh TL; Go VL
    Brain Res; 1988 May; 448(2):294-8. PubMed ID: 3378151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cholecystokinin octapeptide in the central control of food intake in the dog.
    Sakatani N; Inui A; Inoue T; Oya M; Morioka H; Baba S
    Peptides; 1987; 8(4):651-6. PubMed ID: 3306623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the concentration of cholecystokinin-like immunoreactivity in plasma and food intake in male rats.
    Lindén A; Södersten P
    Physiol Behav; 1990 Dec; 48(6):859-63. PubMed ID: 2087518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central and peripheral proglumide administration and cholecystokinin-induced satiety.
    Willis GL; Hansky J; Smith GC
    Regul Pept; 1986 Aug; 15(1):87-98. PubMed ID: 3532220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antagonism by proglumide of various CCK-mediated effects in mice.
    Barbaz BS; Autry WL; Ambrose FG; Gerber R; Liebman JM
    Prog Clin Biol Res; 1985; 192():151-8. PubMed ID: 4080708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of food intake by central administration of cholecystokinin octapeptide in the rat is dependent upon inhibition of brain peptidases.
    Griesbacher T; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1989 Jan; 96(1):236-42. PubMed ID: 2647203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Eur J Pharmacol; 1990 Apr; 179(3):329-38. PubMed ID: 2142090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G; Hsiao S; Itoh S
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of actions of cholecystokinin octapeptide on food intake and insulin and pancreatic polypeptide release in the dog.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Ogawa T; Mizuno N; Baba S
    Peptides; 1988; 9(5):1093-100. PubMed ID: 3072534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
    Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(1):105-10. PubMed ID: 3714527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of amylin on feeding of goldfish: interactions with CCK.
    Thavanathan R; Volkoff H
    Regul Pept; 2006 Jan; 133(1-3):90-6. PubMed ID: 16239037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting.
    Volkoff H; Eykelbosh AJ; Peter RE
    Brain Res; 2003 May; 972(1-2):90-109. PubMed ID: 12711082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of tail-pinch-induced food intake by cholecystokinin octapeptides and their fragments.
    Telegdy G; Kádár T; Kovács K; Penke B
    Life Sci; 1984 Jul; 35(2):163-70. PubMed ID: 6330485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression of rat feeding in familiar and novel environment by sulfated and nonsulfated cholecystokinin octapeptide.
    Kádár T; Penke B; Kovács K; Telegdy G
    Physiol Behav; 1985 Mar; 34(3):395-400. PubMed ID: 4011720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.